Tag: ctso

CytoSorbents Corporation (Nasdaq:CTSO) to Ring The Nasdaq Stock Market Opening Bell

ADVISORY, Dec. 22, 2015 (GLOBE NEWSWIRE) — What:CytoSorbents Corporation (Nasdaq:CTSO), a leader in critical care immunotherapy commercializing its CytoSorb® blood purification technology to reduce deadly uncontrolled inflammation in hospitalized patients around the world, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Dr. Phillip Chan, Chief Executive Officer, will ring the Opening Bell. Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio When:Wednesday, December 23, 2015 – 9:15 a.m. to 9:30 a.m. ET CytoSorbents Corporation Media Contact:Eric Kim, The Ruth Group(646) 536-7012ekim@theruthgroup.com Nasdaq MarketSite:Emily Pan(646) 441-5120emily.pan@nasdaq.com Feed Information:Fiber Line (Encompass Waterfront): 4463

Profile

StockGuru Corporate Profile: $CTSO – Cytosorbents Corp

StockGuru Spotlight on Cytosorbents Corp(Symbol: CTSO) Help us update information on this company. Email any updates to: updates@stockguru.com   About Cytosorbents Corp: CytoSorbents Corporation (OTCBB: CTSO; Monmouth Junction, NJ) is a publicly-traded, critical care immunotherapy company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies from blood.

Latest Spotlights

StockGuru Shines its Spotlight on CytoSorbents Corporation (OTCBB: CTSO) Upon the Announcement of Q3 Results — November 16, 2011

Dallas, Texas (November 16, 2011) – StockGuru Shines its Spotlight on  CytoSorbents Corporation (OTCBB: CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses.  The Company announced its financial results for the third quarter of fiscal 2011, yesterday and closed on November 15, 2011, at $0.132, trading in a fifty-two week range of $0.48 to $0.085. The Company’s research and development costs were $779,589 and $526,043 for the three months ended September 30, 2011 and 2010, respectively. The Company had losses of $1,728,927 and $788,436 for the three months ended September 30, 2011 and 2010, respectively. Historically, the

Latest Spotlights

StockGuru Shines its Spotlight on CytoSorbents Corporation (OTCBB: CTSO) Reports Second Quarter 2011 Financial Results — August 18, 2011

Dallas, Texas (August 18, 2011) – StockGuru Shines its Spotlight on CytoSorbents Corporation (OTCBB: CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses, announced its financial results for the second quarter of fiscal 2011.  The Company closed on August 17, 2011, at $0.18, down 1.6 percent, trading on below its three month average volume and in a fifty-two week range of $0.48 – 0.0651. The Company’s research and development costs were $854,827 and $352,888 for the three months ended June 30, 2011 and 2010, respectively. The Company had losses of $1,341,182 and $676,278 for the three months

Latest Spotlights

StockGuru Spotlight April 1, 2011, Up As Much As: CHCR 325%, THWI 482%, SELR 206%, TPIV 176%, SGLB 325%

StockGuru Spotlights TUCN, CTSO, ACAR, GBGI, ELRA, EMRI, CKGT April 1, 2011 Dear Members: These Spotlights have made tremendous moves. Check out the StockGuru Spotlight potential. While we know you can never catch the absolute high or the absolute low, these Companies represent the StockGuru Spotlight potential. Spotlight Date Spotlight Price Symbol High Up As Much As January 26, 2011 $ 0.20 CHCR $ 0.65 325% March 14, 2011 $ 0.22 THWI $ 1.060 482% January 26, 2011 $ 0.034 SELR $ 0.070 206% March 2, 2011 $ 0.17 TPIV $ 0.30 176% December 22, 2010 $ 0.08 SGLB $

Latest Spotlights

Cytosorbents Corp. is in the StockGuru Spotlight for April 1, 2011

DALLAS, TEXAS : StockGuru announces that Cytosorbents Corp. (OTCBB: CTSO) is in the StockGuru Spotlight.    CytoSorbents Corporation is a critical care focused therapeutic device company in clinical trials to treat severe sepsis, the end result of “overwhelming infection,” with a novel blood purification device called CytoSorb™. Severe sepsis afflicts more than 1 million people in the United States (U.S.), 1.5 million people in the European Union (E.U.), and an estimated 18 million people worldwide each year, killing one in every three patients despite the best medical treatment. In the U.S., more die from severe sepsis than from either heart attacks, strokes

Latest Spotlights

Cytosorbents Corp. is in the StockGuru Spotlight for November 3, 2010

DALLAS, TEXAS : StockGuru announces that Cytosorbents Corp. (OTCBB: CTSO) is in the StockGuru Spotlight.    CytoSorbents Corporation, and its operating subsidiary CytoSorbents, Inc., is a critical care focused therapeutic device company in clinical trials to treat severe sepsis, often called “overwhelming infection,” with a novel blood purification device called CytoSorb™. On Tuesday, the company put out news announcing the award of a cash grant of up to $488,958 from the Federal Qualifying Therapeutic Discovery Project (QTDP) Program for two products in its pipeline, including the development of CytoSorb™ for the treatment of sepsis and other critical care illnesses. Shares for Cytosorbents

Latest Spotlights

Gotta Love a Company with Great Business Plan and Ability to Get Financing and Execute — Add 48% and 50% Increase Since Spotlight — It’s Magic

StockGuru Spotlight October 11, 2010 ICPW, HDVY, GMTD, SELR, CTSO, SCLI, PPRW Dear Members: StockGuru is looking at two stocks on monster runs.  Sit up and take notice here. THMG is a gold mining company that closed on financing with warrants below the closing price yesterday.  There is no news but they took that financing and began drilling, in addition to going on the TSX — which is a great exchange for mining. What’s going on here?  Not moving on news?  But moving beyond warrant price.  This may represent some good results from their exploration. RLGT – Looking Good.  This

Latest Spotlights

Cytosorbents Corp. is in the StockGuru Spotlight for October 12, 2010

DALLAS, TEXAS : StockGuru announces that Cytosorbents Corp. (OTCBB: CTSO) is in the StockGuru Spotlight.    Cytosorbents Corporation, a therapeutic medical device company, engages in the research, development, manufacture, and commercialization of blood purification technologies that would remove middle molecular weight toxins from circulating blood and physiologic fluids. It is developing two products, CytoSorb and BetaSorb utilizing its adsorbent polymer technology. On Monday, the company put out news announcing that the company was chosen to present at the AdvaMed 2010 MedTech Conference at the Walter E. Washington Convention Center in Washington, D.C. next week. Dr. Phillip Chan, Chief Executive Officer, will speak

Latest Spotlights

EVSI – Yesterdays Spotlight Up 15% First Day on News of Solar/Electric Vehicle Charging Station Agreement

StockGuru Spotlight September 2, 2010 CTSO, QTXB, IGEN, GRHU, GHNA BOCL, GIFD Dear Members: We bring you two significant movers today.  First, PHLI is up 75% since our StockGuru Spotlight.  This solid mover is up on strong Q2 financial results.  Net income for the second quarter of 2010 increased to $136,725,  from net income of $12,922 for the same period in 2009.  Obviously, this represents a signficant increase.  Read more about this below. Our second mover was a StockGuru Spotlight yesterday with a 15% mover.  We all know electric cars will need charging stations.  That’s the focus of this company’s

Latest Spotlights

Cytosorbents Corp. is in the StockGuru Spotlight for September 2, 2010

DALLAS, TEXAS : StockGuru announces that Cytosorbents Corp. (OTCBB: CTSO) is in the StockGuru Spotlight.    CytoSorbents Corporation, and its operating subsidiary CytoSorbents, Inc., is a critical care focused therapeutic device company in clinical trials to treat severe sepsis, often called “overwhelming infection,” with a novel blood purification device called CytoSorb™. Severe sepsis afflicts more than 1 million people in the United States and an estimated 18 million people worldwide each year, killing one in every three patients despite the best treatment. In the United States, more die from severe sepsis than from either heart attacks, strokes or any single form of